10-K/A

AMMENDMENT # 3 TO THE FORM 10-K

Company: Oncotelic Therapeutics, Inc.
Filed: August 12, 2003
Period of Report: December 31, 2002
Accession Number: 0001193125-03-033306

View Document ↗ View on SEC.gov ↗